Stockscreener 앱 받기
144.80
0.01%
-0.0695
Biogen Inc 주식(BIIB)의 최신 뉴스
Biogen (BIIB) to Acquire Alcyone Therapeutics for $85M - GuruFocus
December 19th Options Now Available For Biogen (BIIB) - Nasdaq
Biogen acquires Lowell firm developing device meant replace the spinal tap - The Business Journals
Biogen to acquire Alcyone Therapeutics - The Pharma Letter
Biogen to buy startup Alcyone, eyeing easier delivery of RNA drugs - BioPharma Dive
Biogen Inc. entered into a definitive agreement to acquire All Assets of Alcyone Therapeutics, Inc. for $85 million. - MarketScreener
Biogen Gets EU Nod for First Postpartum Depression Drug - Yahoo Finance
Biogen to buy Massachusetts-based Alcyone Therapeutics (BIIB:NASDAQ) - Seeking Alpha
Biogen To Acquire Alcyone Therapeutics - Nasdaq
Biogen to Acquire Alcyone Therapeutics for Initial $85 million - MarketScreener
Biogen (BIIB) to Acquire Alcyone Therapeutics for Innovative Dru - GuruFocus
Biogen to acquire Alcyone Therapeutics for $85 million - Investing.com
Biogen to buy Alcyone Therapeutics, expanding drug delivery solutions for key products and pipeline - MarketScreener
Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates - Biogen
Biogen’s Zurzuvae approved as first postpartum depression drug in Europe - Yahoo Finance
EC nod for Biogen’s PPD drug Zurzuvae - The Pharma Letter
EC approves Biogen’s ZURZUVAE as first oral treatment for postpartum depression - Investing.com Australia
MBB Public Markets I LLC Acquires Shares of 2,150 Biogen Inc. $BIIB - MarketBeat
34,000 Shares in Biogen Inc. $BIIB Purchased by Strs Ohio - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Sells 23,427 Shares of Biogen Inc. $BIIB - MarketBeat
Jacobi Capital Management LLC Acquires 2,064 Shares of Biogen Inc. $BIIB - MarketBeat
Swedbank AB Has $29.84 Million Holdings in Biogen Inc. $BIIB - MarketBeat
Pullback Watch: Can Biogen Inc. sustain its profitability2025 Technical Patterns & Daily Oversold Stock Bounce Ideas - خودرو بانک
Aug PostEarnings: Can Biogen Inc outperform in the next rally2025 Major Catalysts & Precise Swing Trade Entry Alerts - خودرو بانک
Biogen (BIIB) Gains EU Approval for Post-Partum Depression Treat - GuruFocus
Biogen (BIIB) Receives E.U. Approval for ZURZUVAE in Treating Po - GuruFocus
Biogen receives European Commission approval for Zurzuvae - MarketScreener
Biogen gets EU nod for Zurzuvae to treat post-partum depression - MSN
Biogen Receives European Commission Approval for ZURZUVAE® to Treat Postpartum Depression - Quiver Quantitative
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe - Biogen
First-Ever Oral Postpartum Depression Treatment: Biogen's ZURZUVAE Gets EU Green Light for 14-Day Therapy - Stock Titan
Biogen (BIIB) Receives a Hold from J.P. Morgan - The Globe and Mail
Biogen Inc. $BIIB Shares Acquired by Woodline Partners LP - MarketBeat
United Services Automobile Association Purchases Shares of 3,604 Biogen Inc. $BIIB - MarketBeat
Voya Investment Management LLC Reduces Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Acadian Asset Management LLC Purchases 14,357 Shares of Biogen Inc. $BIIB - MarketBeat
Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way - Yahoo Finance
1.41%
자본화:
|
볼륨(24시간):